Inflammatory arthritis resulting from immune checkpoint inhibitor use is immunologically unique and likely driven by T cells ...

Two therapies can be better than one for treating some cancers, concludes a Yale study published Oct. 22 in JCI Insight that ...

The winner of a 2025 SITC grant examines mechanisms that may help explain why drugs that work for some forms of lymphoma ...

Melanoma is the most common form of skin cancer, but for patients with advanced melanoma who no longer respond to standard ...

Patients with an aggressive form of breast cancer who are not candidates for immune checkpoint inhibitor therapy showed ...

Please provide your email address to receive an email when new articles are posted on . Patients who received PD-1 or PD-L1 agents exhibited increased risk for psoriasis. Medical professionals should ...

Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Use of immune checkpoint inhibitors for cancer was associated ...

FRIDAY, Oct. 24, 2025 (HealthDay News) — The mRNA technology powering some COVID vaccines may hold a surprising benefit for ...

A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...

A nationwide cohort study in Taiwan found a higher risk of psoriasis in cancer patients treated with immune checkpoint inhibitors compared to other therapies. The study analyzed data from 3,188 ...